Solveig G. Ericson
Affiliations: | West Virginia University, Morgantown, WV, United States |
Area:
Immunology, Molecular BiologyGoogle:
"Solveig Ericson"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Miller JL, Ericson SG. (2007) Cyclosporin a and tacrolimus (FK506) differentially alter T-cell receptor expression in vivo. Immunopharmacology and Immunotoxicology. 29: 105-18 |
| Kurian S, Qazilbash M, Fay J, et al. (2006) Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit Breast Journal. 12: 531-535 |
| Saad A, Visweshwar N, Sehbai A, et al. (2006) Correlation of CD3 and CD34 cell dose with incidence of acute GVHD in myeloablative stem cell transplantation Journal of Clinical Oncology. 24: 6553-6553 |
| Saad AA, Fortney J, Wang L, et al. (2006) Disruption of the Crosstalk CXCL12/CXCR4 Chemotactic Pathway To Enhance Melphalan-Induced Apoptosis in Multiple Myeloma Cell Lines. Blood. 108: 3445-3445 |
| Campbell-Fontaine A, Coad JE, Kovach R, et al. (2005) Adoptive transfer of vitiligo after allogeneic peripheral blood stem cell transplant. Bone Marrow Transplantation. 36: 745-6 |
| Brewer JL, Ericson SG. (2005) An improved methodology to detect human T cell receptor beta variable family gene expression patterns. Journal of Immunological Methods. 302: 54-67 |
| Devetten MP, Qazilbash MH, Beall CL, et al. (2005) Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial. Bone Marrow Transplantation. 34: 577-80 |
| Devetten MP, Loberiza F, Weisenborn R, et al. (2005) Low Dose Alemtuzumab (Campath 1H) Prior to Allogeneic Stem Cell Transplantation Is Associated with Low Incidence of Acute and Chronic GVHD but Protracted Immune Recovery. Blood. 106: 5376-5376 |
| Craig M, Cumpston A, Shields R, et al. (2005) Evaluation of antibiotic cycling and prophylaxis for neutropenic fever within a blood and marrow transplantation unit Biology of Blood and Marrow Transplantation. 11: 89-90 |
| Craig M, Yao Y, Ericson S. (2004) Comparison of G-CSF Administration Starting Day +5 Versus Based on White Blood Count Following Autologous Peripheral Blood Stem Cell Transplantation. Blood. 104: 5053-5053 |